Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Merck & Co., Inc.    MRK

MERCK & CO., INC.

(MRK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Merck & Co., Inc. : Buyers are coming back

08/03/2020 | 11:25am EST
long trade
Stop-loss triggered
Entry price : 83.1674$ | Target : 87.9$ | Stop-loss : 79.7$ | Potential : 5.69%
Merck & Co., Inc. shares have recently experienced an upward movement with a return of higher volumes and volatility. This technical chart pattern suggests a continuation of the upward movement.
Investors have an opportunity to buy the stock and target the $ 87.9.
Merck & Co., Inc. : Merck & Co., Inc. : Buyers are coming back
Strengths
  • There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
  • Analysts covering this company mostly recommend stock overweighting or purchase.

Weaknesses
  • The group usually releases earnings worse than estimated.
  • The company's enterprise value to sales, at 4.55 times its current sales, is high.

© MarketScreener.com 2020

Disclaimer: The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.

Financials (USD)
Sales 2020 48 203 M - -
Net income 2020 12 158 M - -
Net Debt 2020 15 159 M - -
P/E ratio 2020 16,3x
Yield 2020 3,18%
Capitalization 195 B 195 B -
EV / Sales 2020 4,36x
EV / Sales 2021 4,01x
Nbr of Employees 71 000
Free-Float 70,7%
Upcoming event on MERCK & CO., INC.
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 23
Average target price 97,05 $
Last Close Price 77,07 $
Spread / Highest target 38,8%
Spread / Average Target 25,9%
Spread / Lowest Target 10,3%
EPS Revisions
Managers and Directors
NameTitle
Kenneth C. Frazier Chairman, President & Chief Executive Officer
Robert M. Davis CFO & Executive Vice President-Global Services
Sandy Tremps Vice President-R&D IT CIO
Thomas Henry Glocer Independent Director
Leslie A. Brun Lead Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
MERCK & CO., INC.-5.78%194 990
JOHNSON & JOHNSON6.67%448 796
ROCHE HOLDING AG4.51%312 213
NOVARTIS AG0.81%214 457
PFIZER INC.-1.55%207 384
ELI LILLY AND COMPANY22.94%192 848